BRIDGEWATER, NJ--(Marketwire - July 30, 2008) - Alpharma Inc. (NYSE: ALO), a global specialty pharmaceutical company, today announced a second quarter 2008 diluted loss per share of $0.02 from its continuing operations. The Company’s second quarter 2008 financial performance from continuing operations reflects:
